To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:September 26, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:September 26, 2023Terminated
Condition(s):Metastatic Castration Resistant Prostate Cancer (CRPC)Last Updated:December 5, 2013Unknown status
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:March 21, 2024Completed
Condition(s):Metastatic Castration-Resistant Prostate CancerLast Updated:November 20, 2017Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 13, 2023Active, not recruiting
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:April 19, 2018Terminated
Condition(s):Metastatic Castration-Resistant Prostate Cancer; Metastatic Castration-Sensitive Prostate Cancer; Non-Metastatic Castration-Resistant Prostate CancerLast Updated:September 6, 2022Recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:December 19, 2018Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:December 29, 2023Active, not recruiting
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:August 14, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.